CLINICAL_TRIALS
trial_result
· 2024-12-24
Clinical Trial Update: Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension [Phase 2]
Summary
A Phase 2 clinical trial evaluating the acute hemodynamic effects of TPN171H in patients with pulmonary arterial hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vigonvita Life Sciences | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED